annual accounts payable:
$197.40M+$10.80M(+5.79%)Summary
- As of today (August 27, 2025), EW annual accounts payable is $197.40 million, with the most recent change of +$10.80 million (+5.79%) on December 31, 2024.
- During the last 3 years, EW annual accounts payable has fallen by -$7.10 million (-3.47%).
- EW annual accounts payable is now -3.47% below its all-time high of $204.50 million, reached on December 31, 2021.
Performance
EW Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$162.10M-$10.30M(-5.97%)Summary
- As of today (August 27, 2025), EW quarterly accounts payable is $162.10 million, with the most recent change of -$10.30 million (-5.97%) on June 30, 2025.
- Over the past year, EW quarterly accounts payable has dropped by -$23.80 million (-12.80%).
- EW quarterly accounts payable is now -70.01% below its all-time high of $540.50 million, reached on June 30, 2014.
Performance
EW quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
EW Accounts payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +5.8% | -12.8% |
3 y3 years | -3.5% | -0.3% |
5 y5 years | +9.4% | +5.7% |
EW Accounts payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -3.5% | +5.8% | -23.6% | +4.7% |
5 y | 5-year | -3.5% | +9.4% | -23.6% | +16.2% |
alltime | all time | -3.5% | +314.7% | -70.0% | +234.9% |
EW Accounts payable History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $162.10M(-6.0%) |
Mar 2025 | - | $172.40M(-12.7%) |
Dec 2024 | $197.40M(+5.8%) | $197.40M(+14.2%) |
Sep 2024 | - | $172.80M(-7.0%) |
Jun 2024 | - | $185.90M(-12.4%) |
Mar 2024 | - | $212.30M(+13.8%) |
Dec 2023 | $186.60M(-7.6%) | $186.60M(-2.1%) |
Sep 2023 | - | $190.60M(-1.2%) |
Jun 2023 | - | $193.00M(+6.7%) |
Mar 2023 | - | $180.80M(-10.5%) |
Dec 2022 | $201.90M(-1.3%) | $201.90M(+30.3%) |
Sep 2022 | - | $154.90M(-4.7%) |
Jun 2022 | - | $162.50M(+2.3%) |
Mar 2022 | - | $158.80M(-22.3%) |
Dec 2021 | $204.50M(+4.1%) | $204.50M(+46.6%) |
Sep 2021 | - | $139.50M(-3.5%) |
Jun 2021 | - | $144.60M(-3.9%) |
Mar 2021 | - | $150.40M(-23.5%) |
Dec 2020 | $196.50M(+8.9%) | $196.50M(+20.9%) |
Sep 2020 | - | $162.50M(+5.9%) |
Jun 2020 | - | $153.40M(+1.3%) |
Mar 2020 | - | $151.50M(-16.0%) |
Dec 2019 | $180.40M(+34.6%) | $180.40M(+32.7%) |
Sep 2019 | - | $135.90M(-10.0%) |
Jun 2019 | - | $151.00M(+2.6%) |
Mar 2019 | - | $147.20M(+9.9%) |
Dec 2018 | $134.00M(+14.9%) | $134.00M(0.0%) |
Sep 2018 | - | $134.00M(+7.5%) |
Jun 2018 | - | $124.60M(+2.8%) |
Mar 2018 | - | $121.20M(+3.9%) |
Dec 2017 | $116.60M(+20.1%) | $116.60M(+2.8%) |
Sep 2017 | - | $113.40M(+8.4%) |
Jun 2017 | - | $104.60M(+12.5%) |
Mar 2017 | - | $93.00M(-4.2%) |
Dec 2016 | $97.10M(+52.0%) | $97.10M(+11.6%) |
Sep 2016 | - | $87.00M(+4.3%) |
Jun 2016 | - | $83.40M(+6.1%) |
Mar 2016 | - | $78.60M(+23.0%) |
Dec 2015 | $63.90M(+9.8%) | $63.90M(-10.6%) |
Sep 2015 | - | $71.50M(+8.0%) |
Jun 2015 | - | $66.20M(-3.5%) |
Mar 2015 | - | $68.60M(+17.9%) |
Dec 2014 | $58.20M(+20.2%) | $58.20M(-2.8%) |
Sep 2014 | - | $59.90M(-88.9%) |
Jun 2014 | - | $540.50M(+51.7%) |
Mar 2014 | - | $356.20M(+636.0%) |
Dec 2013 | $48.40M(-35.2%) | $48.40M(-85.6%) |
Sep 2013 | - | $335.10M(+6.7%) |
Jun 2013 | - | $314.20M(+4.6%) |
Mar 2013 | - | $300.40M(-13.5%) |
Dec 2012 | $74.70M | $347.40M(+16.3%) |
Sep 2012 | - | $298.60M(+5.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2012 | - | $284.30M(+7.2%) |
Mar 2012 | - | $265.20M(-20.9%) |
Dec 2011 | $85.00M(+78.6%) | $335.20M(+11.0%) |
Sep 2011 | - | $302.00M(-3.6%) |
Jun 2011 | - | $313.30M(+6.0%) |
Mar 2011 | - | $295.70M(-0.1%) |
Dec 2010 | $47.60M(-6.8%) | $296.00M(+5.1%) |
Sep 2010 | - | $281.60M(+13.7%) |
Jun 2010 | - | $247.70M(+2.3%) |
Mar 2010 | - | $242.20M(-16.6%) |
Dec 2009 | $51.10M(-22.1%) | $290.50M(-2.0%) |
Sep 2009 | - | $296.30M(+20.9%) |
Jun 2009 | - | $245.10M(+22.4%) |
Mar 2009 | - | $200.20M(-22.6%) |
Dec 2008 | $65.60M(+2.7%) | $258.50M(+12.4%) |
Sep 2008 | - | $229.90M(+1.5%) |
Jun 2008 | - | $226.60M(-6.2%) |
Mar 2008 | - | $241.60M(+7.2%) |
Dec 2007 | $63.90M(+11.7%) | $225.40M(+13.4%) |
Sep 2007 | - | $198.80M(+14.5%) |
Jun 2007 | - | $173.60M(-3.2%) |
Mar 2007 | - | $179.40M(-20.7%) |
Dec 2006 | $57.20M(-5.8%) | $226.20M(-0.6%) |
Sep 2006 | - | $227.50M(+0.4%) |
Jun 2006 | - | $226.50M(+15.3%) |
Mar 2006 | - | $196.50M(+1.2%) |
Dec 2005 | $60.70M(-2.1%) | $194.20M(-5.1%) |
Sep 2005 | - | $204.60M(+7.5%) |
Jun 2005 | - | $190.40M(+7.9%) |
Mar 2005 | - | $176.40M(-9.7%) |
Dec 2004 | $62.00M(-7.9%) | $195.40M(+14.7%) |
Sep 2004 | - | $170.30M(+9.2%) |
Jun 2004 | - | $156.00M(-0.3%) |
Mar 2004 | - | $156.40M(-6.5%) |
Dec 2003 | $67.30M(-3.2%) | $167.20M(-2.8%) |
Sep 2003 | - | $172.00M(-7.6%) |
Jun 2003 | - | $186.10M(-1.8%) |
Mar 2003 | - | $189.60M(-4.2%) |
Dec 2002 | $69.50M(+36.3%) | $197.90M(+13.1%) |
Sep 2002 | - | $175.00M(-5.7%) |
Jun 2002 | - | $185.50M(+11.5%) |
Mar 2002 | - | $166.30M(-9.1%) |
Dec 2001 | $51.00M(+4.1%) | $183.00M(+16.4%) |
Sep 2001 | - | $157.20M(+4.9%) |
Jun 2001 | - | $149.90M(-10.5%) |
Mar 2001 | - | $167.40M(+5.9%) |
Dec 2000 | $49.00M(-64.2%) | $158.00M(+24.6%) |
Sep 2000 | - | $126.80M(+4.8%) |
Jun 2000 | - | $121.00M(-0.8%) |
Mar 2000 | - | $122.00M |
Dec 1999 | $137.00M(+149.1%) | - |
Dec 1998 | $55.00M | - |
FAQ
- What is Edwards Lifesciences Corporation annual accounts payable?
- What is the all time high annual accounts payable for Edwards Lifesciences Corporation?
- What is Edwards Lifesciences Corporation annual accounts payable year-on-year change?
- What is Edwards Lifesciences Corporation quarterly accounts payable?
- What is the all time high quarterly accounts payable for Edwards Lifesciences Corporation?
- What is Edwards Lifesciences Corporation quarterly accounts payable year-on-year change?
What is Edwards Lifesciences Corporation annual accounts payable?
The current annual accounts payable of EW is $197.40M
What is the all time high annual accounts payable for Edwards Lifesciences Corporation?
Edwards Lifesciences Corporation all-time high annual accounts payable is $204.50M
What is Edwards Lifesciences Corporation annual accounts payable year-on-year change?
Over the past year, EW annual accounts payable has changed by +$10.80M (+5.79%)
What is Edwards Lifesciences Corporation quarterly accounts payable?
The current quarterly accounts payable of EW is $162.10M
What is the all time high quarterly accounts payable for Edwards Lifesciences Corporation?
Edwards Lifesciences Corporation all-time high quarterly accounts payable is $540.50M
What is Edwards Lifesciences Corporation quarterly accounts payable year-on-year change?
Over the past year, EW quarterly accounts payable has changed by -$23.80M (-12.80%)